TheProfitWatch

CCCC - C4 Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.34 0.1 (4.27%) 0.0 (0.21%) 0.0 (0.21%) 0.01 (0.42%) 0.0 (0.0%) 0.04 (1.67%) 0.0 (0.03%) -0.04 (-1.67%)

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.37
Diluted EPS:
-0.37
Basic P/E:
-6.5946
Diluted P/E:
-6.5946
RSI(14) 1m:
92.54
VWAP:
2.44
RVol:

Events

Period Kind Movement Occurred At

Related News